• Work with us
  • External Contractors
Fondazione Toscana Life Sciences
  • IT
  • EN
Toscana Life Sciences
  • THE FOUNDATION
    • Organization
    • History
    • Membership
    • The Legislative Decree No. 231/2001
  • Activity
  • Cluster
  • ITS VITA
  • BIOINCUBATOR
    • Join the Bioincubator
    • Incubated companies
    • Research groups
    • Affiliated companies
  • Services
    • Business development services
    • Research services
    • Incubation services
    • Protection of intellectual property
  • Projects
    • Advanced ERC Grant OMVac
    • Advanced ERC Grant vAMRes
    • Regions4PerMed
    • COSME-AI4DIAG
    • IDF SHARID
  • Disseminating
    • TLS Open Doors
    • Scientists for a day
    • Science + Economy = Business
    • Researcher’s Night
    • European Biotech Week
  • Orphan diseases
  • Stories
Enter any keyword and press enter


Davide Zocco

Head of Molecular Diagnostics Exosomics Siena SPA



Download Watch video


Looking to gain time


EXOSOMICS Siena SpA

Cancer screening and diagnosis with exosomes


Exosomics Siena was born in 2011 as spin-off of HansaBioMed OU for the exploitation of technologies applied to the oncological diagnostics. Exosomics is located at Medical Research Center of Toscana Life Sciences Foundation since 2012 and represents a very innovative company in the oncology field. The main company interests are new platforms for cancer screening and diagnostics for personalized therapie of oncological patients. Exosomics employs the exsomomes properties as markers vehicles in the peripheral blood in order to obtain relevant diagnostic information. As Antonio Chiesi, company founder and CEO, explains in his interview, the exosomes are lipid nanoparticles released in the biological fluids from all cells and, in particular, from the cancer tissues, which transmit disease’s markers (proteins and nucleic acids) in the blood. Through the content analysis of these nanoparticles it is possible to obtain an accurate cancer diagnosis.
The aim of Exosomics Siena is to revolutionize the oncology diagnostics field through the use of screening essays for the precision medicine with an high innovation content.
The company asset has recently increased with the arrival of an important international partner, LONZA, which invested on technologies and on the innovative approach proposed by Exosomics Siena to improve the cancer diagnostics. The company also cooperates with many national and international clinical groups in the development and validation of its own diagnostic products and in the optimisation of innovative technologies in the field of liquid biopsy.

For more information: www.exosomics.eu

Read more

Fondazione Umberto Di Mario

Diabetes is not invincible
read more


ISTITUTO TOSCANO TUMORI

Cancer can be defeated through the cooperation
read more


LEAD DISCOVERY SIENA

From research to drug: it’s a matter of chemistry
read more


SIENA IMAGING

The human brain as you have never seen it
read more


T4ALL

Technology at the service of everyone
read more


Fondazione Toscana Life Sciences
Via Fiorentina, 1
53100 Siena – ITALIA

  • tel +39 0577 231211
  • fax +39 0577 43444
  • info@toscanalifesciences.org; info@pec.fondazionetls.org

Twitter Feeds

🗣Nuovo appuntamento con Region4PerMed. 📍Lunedì 27 e martedì 28 giugno Siena ospita la nuova conferenza del progetto…

@FondazioneTLS 19 Hours Ago

🗣Nuovo appuntamento con @Regions4PerMed 📍Lunedì 27 giugno e martedì 28 giugno, Siena ospita la nuova conferenza su…

@FondazioneTLS 2 Days Ago

La Fondazione Tls è alla ricerca di un Senior Data Scientist (Computational Structural Biologist). 🗣 Per candidart…

@FondazioneTLS 2 Days Ago

Contatti

    Concedo il consenso al trattamento dei dati personali secondo la nostra Privacy Policy per poter essere contattato da Fondazione Toscana Life Sciences.

©2015-2019 - Fondazione Toscana Life Sciences - P.I. 01194710529 - Codice SDI: SUBM70N - Privacy - Cookie Policy